Alimentary tract, also called as
alimentary canal,digestive tract/tube, gastrointestinal tract is a
hollow passageway of;mucous membrane and muscles that function in
digestion. The alimentary canal consists of the mouth,esophagus stomach,
small intestine,large intestine, and anus.Metabolism is a biochemical
reaction and physical procedure that encompasses maintenance of various
functions, such as breathing, blood circulation, muscles movement,
digestion of food and nutrients, waste elimination, body temperature
control, and proper functioning of brain and nerves of the organism.
Metabolism is a pathway that starts with a series of biochemical
reactions with a specific molecule and ends with a product with the help
of specific enzyme. It is categorized into two processes, i.e.
catabolism and anabolism. Catabolism involves breaking down of molecules
into simpler energy yielding forms while anabolism involves synthesis
of compounds or elements needed by the cell for proper functions.
The disorders related to alimentary tract
and metabolism are of very common occurrence and hold high medical
significance along with cardiovascular and infectious diseases. The
alimentary tract disorders are associated with the impairment of
gastrointestinal functions of the system. Improper functioning of
gastrointestinal tract can lead to a variety of disorders including
irritable bowel syndrome, gastroesophageal reflux diseases, peptic
ulcers, constipation, hemorrhoids, colitis, etc. The major causes of
these ailments vary and could include genetic abnormalities, the side
effects of certain toxins and drugs, infections, cancer, and others.
These disorders not only hamper the natural digestive system of the body
but also have significant effects on the body metabolism. Some of the
most popular brands available in the market for alimentary tract and
metabolism are Nexium, Aciphex, Tysabri, and Humira. Growing prevalence
of digestive disorders will enhance the growth of alimentary tract and
metabolism market. In addition, growing stress, unhealthy dietary
lifestyles and increasing geriatric population drives the growth of this
market. Furthermore, increasing research and development activities by
key players to develop new drugs will further determine the market
growth.
On the basis of products, the alimentary
tract and metabolism market can be divided into a variety of products
used to manage various alimentary tract conditions that includes
stomatological preparations, functional gastrointestinal disorders,
antacids, antinauseants, laxatives, antidiarrheals, intestinal
antiinflammatory/antiinfective agents, antiobesity preparations,
vitamins, mineral supplements, tonics, anabolic agents for systemic use,
other alimentary tract and metabolism products. Increasing incidences
of lifestyle related disorders is one of the major driver for alimentary
tract and metabolism market globally.
Geographically, the alimentary tract and
metabolism market can be segmented into North America, Europe, Asia
Pacific, the Middle East & Africa and Latin America. In 2015, North
America dominated the market due to large pool of patients of
gastrointestinal disorders in the region. According to the National
Institute of Diabetes and Digestive and Kidney Diseases, more than 60
million Americans suffer from one or the other type of digestive
diseases annually. Moreover, the rising incidences of colorectal cancer
in the United States also support the market growth. The diet has
reduced the intake of various healthy foods that increases the incidence
of digestive tract problems. Additionally, new and advanced products
launches by key players coupled with growing uptake of these drugs by
customers further drive the market growth. Developing nations in Asia
Pacific are expected to witness the fastest growth during the forecast
period. Growing patient pool, increased public awareness and increasing
affordability are the major drivers for the market growth in these
geographies.
Key players having presence in the
alimentary tract and metabolism market include Abbott Laboratories,
AstraZeneca, Eisai Co., Ltd., Eli Lilly and Company, F Hoffmann-La
Roche, Johnson & Johnson, Novartis AG, Merck KGaA, Sanofi-Aventis,
Takeda Pharmaceutical Company.
No comments:
Post a Comment